Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
复制标题
网络荟萃分析:识别临床显著门脉高压的非侵入性成像方式。
DOI:
10.1007/s10620-021-07168-y
复制
发表时间:
2022-07
影响因子:
3.1
通讯作者:
Forsberg F
中科院分区:
文献类型:
--
作者:
Hai Y;Chong W;Eisenbrey JR;Forsberg F
Although measurement of the hepatic venous pressure gradient (HVPG) is the current reference standard for obtaining portal venous pressures, several non-invasive imaging-based modalities have been proposed as alternatives. We performed a systematic review and meta-analysis to compare the diagnostic accuracy of non-invasive imaging approaches for identifying clinically significant portal hypertension (CSPH). Two independent reviewers conducted a literature search of PubMed, SCOPUS, and the Cochrane Library from inception until January 5th, 2021. The following imaging modalities were compared to HVPG: computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance elastography (MRE), ultrasound, transient elastography (TE), shear wave elastography (SWE), acoustic radiation force impulse (ARFI) imaging, contrast-enhanced ultrasound (CEUS), and subharmonic aided pressure estimation (SHAPE). Sensitivity, specificity, diagnostic odds ratio (DOR), and area under the curve (AUC) for summary receiver operating characteristic (SROC) were calculated using both frequentist random-effects and Bayesian network meta-analytic approaches. We analyzed 45 studies of 5678 patients. A broad overlapping confidence interval (CI) of DOR was observed among different imaging modalities: ARFI (30.5; 95% CI 12.7–73.3), CEUS and SHAPE (21.1; 95% CI 6.4–69.8), TE of liver stiffness (21.1; 95% CI 13.3–33.5), CT and MRI (13.7; 95% CI 7.40–25.4), SWE of liver stiffness (10.5; 95% CI 5.2–21.1), and ultrasound (9.5; 95% CI 4.9–18.4). The AUC of all imaging methods exceeded 0.8, indicating very good performance. At a cut-off of 80% specificity, TE, CEUS and SHAPE exceeded 80% sensitivity. Overall, non-invasive imaging modalities perform well for identifying CSPH. Clinicians should consider these non-invasive and cost-efficient tests when diagnosing CSPH.
登录
查看更多内容
影响因子:
29.4
作者:
Huwart, Laurent;Sempoux, Christine;Van Beers, Bernard E.
通讯作者:
Van Beers, Bernard E.
影响因子:
7.6
作者:
Bureau, C.;Metivier, S.;Vinel, J. P.
通讯作者:
Vinel, J. P.
影响因子:
29.4
作者:
Colecchia, Antonio;Montrone, Lucia;Festi, Davide
通讯作者:
Festi, Davide
影响因子:
4.8
作者:
Jeon, Sun Kyung;Lee, Jeong Min;Han, Joon Koo
通讯作者:
Han, Joon Koo
影响因子:
19.7
作者:
Gupta, Ipshita;Eisenbrey, John R.;Forsberg, Flemming
通讯作者:
Forsberg, Flemming